Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=4
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=4
Search /vufind/Search2/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=4
PubPharm (481.412)
31
Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) : Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
32
NHLBI-Emory Advanced Cardiac CT Reconstruction : NHLBI-Emory Advanced Cardiac CT Reconstruction
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
33
Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia : A 6-Week, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Cariprazine in the Acute Exacerbation of Schizophrenia, With an Additional 18-Week Blinded Extension Period
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
34
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors : Phase 1 Umbrella Trial of Erlotinib In Combination With Select Tyrosine Kinase Inhibitors In Adult Patients With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
35
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma : A Phase II Sequential Window of Opportunity Trial of Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
36
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer : A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
37
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer : A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
38
ACP-204 in Adults With Alzheimer's Disease Psychosis : A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
39
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) : A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
40
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) : Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48142]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
481.410
Aufsätze
481.170
E-Ressourcen
481.168
E-Artikel
242
Gedruckte Aufsätze
2
E-Zeitschriften
2
Zeitschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
480.607
ClinicalTrials.gov
77
Arthritis & rheumatism
30
Arthritis care & research
27
PloS one
24
Trials
22
The pink sheet
18
The New England journal of medicine
18
Therapeutic innovation & regulatory science
16
PLoS ONE
12
BMJ open
12
Contemporary clinical trials
11
Journal of clinical epidemiology
10
Drug safety
9
BMC medical research methodology
9
BMC medicine
8
BMJ (Clinical research ed.)
8
JAMA
8
Journal of general internal medicine
8
bioRxiv.org
7
Clinical trials (London, England)
Alle anzeigen ...
weniger ...
Thema
480.581
610
368.127
Study Type: Interventional
252.750
Recruitment Status: Completed
105.780
Study Type: Observational
88.071
Recruitment Status: Recruiting
53.536
Phase: Phase 2
41.001
Phase: Phase 1
36.186
Recruitment Status: Unknown status
35.755
Phase: Phase 3
31.525
Phase: Phase 4
28.317
Recruitment Status: Not yet recruiting
27.213
Recruitment Status: Terminated
25.700
Recruitment Status: Active, not recruiting
13.631
Recruitment Status: Withdrawn
10.204
Breast Neoplasms
10.083
Diabetes Mellitus
9.835
Syndrome
8.315
Carcinoma
8.288
Neoplasms
7.872
Diabetes Mellitus, Type 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
271.834
2020-
194.481
2010-2019
15.113
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
481.206
Englisch
9
Chinesisch
1
Deutsch
Haven't found what you're looking for?
Wird geladen...